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Background. Few studies have analysed the natural course of cerebral ischaemia for predicting outcome. We aimed to determine
the early clinical ﬁndings and the thresholds for deﬁcit severity and symptom duration that make it possible to stratify outcome.
Methods. We included 154 patients with transient ischaemic attack or ischaemic stroke. Stroke proﬁles and neurological status
were assessed from onset to 24hrs, on admission, at 48hrs, and at discharge. Outcomes were evaluated using the modiﬁed Rankin
Scale.Positiveandnegativepredictivevalueswerecalculatedforthediﬀerentthresholds.Themodelwassubsequentlyevaluatedon
a new prospective cohort of 157 patients. Results. Initial National Institute of Health Stroke Scale (NIHSS) score <5 and symptoms
regressing within 135min were predictive of good outcome. Initial NIHSS score >22 and symptom stability after 1,230min were
predictive of physical dependency or death. Conclusions. Low and high NIHSS cut-oﬀ points are eﬀective positive predictive values
for good and poor outcomes. Thresholds for symptom duration are less conclusive.
1.Introduction
The majority of studies on the prehospitalisation phase
of cerebral ischaemia (ischaemic stroke [IS] and transient
ischaemic attack [TIA]) have largely been conducted by
emergency medical personnel [1–3] and have primarily
focused on technical considerations, general practitioners’
(GP) knowledge of cerebrovascular events, the time lapses
before medical care is sought, and the measures needed to
shorten these delays.
However, the dynamic nature of cerebral ischaemia
has been emphasised [4], and the process—in terms of
time and space—involved in the transition from reversible
ischaemia to irreversible infarction is not a uniform one.
This may explain the extremely variable outcomes for any
given trunk occlusion, including the “spectacular shrinking
deﬁcit” described by Kraemer et al. [5]. Evidence suggests
that management of IS patients is not always adapted to
individual pathophysiological states and that the natural
course of IS needs to be assessed with an array of simple and
available tests. Rapid assessment is all the more crucial given
that thrombolytic treatment is highly time dependent (<3
hours after symptom onset). Although the management of
cerebral ischaemia is considerably helped by neuroimaging
techniques such as diﬀusion-perfusion MR imaging (DWI-
PWI), these techniques cannot replace clinical ﬁndings such
as symptom intensity and duration. Identifying the initial
course and thresholds may constitute a predictive diagnostic
tool and lead to better acute management of stroke. Indeed
placebo group analyses from pivot studies have demon-
strated a good reliability between baseline National Institutes
of Health Stroke Scale (NIHSS) scores on admission and
functional outcome or hospital disposition after stroke [6–
8]. To our knowledge, only one recent study has speciﬁcally
analysed the natural course of cerebral ischaemia to predict
outcome [9].
The aims of this study were ﬁrstly to determine the early
clinicalﬁndingsthatarepredictiveofoutcomeinacutestoke,
and secondly, to establish the thresholds for deﬁcit severity
and symptom duration that make it possible to stratify
outcome.2 ISRN Neurology
2. Patientsand Methods
2.1. Study Population. The study had a prospective, observa-
tional cohort design. From September 2000 to March 2001,
patients admitted to Besanc ¸on University Hospital within
24 hours of symptom onset with clinical and neuroimaging
patterns of IS or TIA were screened for inclusion in the
study (n = 361). We selected arterial ischaemia and excluded
cerebral venous thrombosis and intracerebral haematoma or
patientswhohadpreviouslyhadastrokeandweredependent
(corresponding to a modiﬁed Rankin Scale (mRS) score
of 3). Patients were excluded as follows: 98 were admitted
without consulting a GP, 27 had intraparenchymatous
haematoma,4hadcerebralvenousthrombosis,24ISpatients
were admitted >24 hours after symptom onset and two were
receiving thrombolytic therapy. Among the 206 IS patients
admitted within <24 hours, 52 were excluded when the
precise course of their symptoms could not be obtained
(n = 32), because the GP could not be contacted or could
not establish relevant and detailed clinical patterns (n = 18),
or when the patient showed symptoms of events similar
to IS (epilepsy, migraine) which could cast doubt on their
diagnosis (2 cases). The remaining 154 eligible patients were
assessed according to the Besanc ¸on Stroke Registry criteria,
reported in greater detail elsewhere [10]. TIA was deﬁned
according to a symptom duration of <24 hours (pre-2004
deﬁnition) [11]. For the purposes of this study, posterior and
anterior circulation strokes were not diﬀerentiated, and side
of deﬁcit was not speciﬁed.
2.2. Scoring and Questionnaire. Two scores were used to
assess prehospitalisation clinical status. The ﬁrst, termed
the “Neurological Dysfunction Score” (NDS), reﬂected the
patient’s and/or his/her family’s evaluation of the symp-
toms and their variation prior to assessment on admission
(Table 3). This initial NDS, termed “NDS-0,” deﬁned the
initial onset time of the symptoms. The second score was
the NIHSS retrospectively estimated by the GP, termed
“NIHSS-GP.” For patients who had been referred by a GP,
NIHSS-GP was performed as soon as possible (up to 12
hours) after admission by a phone interview with the GP
using a standard procedure. Upon admission, the in-hospital
clinical examination was carried out to establish a new NDS
(NDS-1) and an admission NIHSS (NIHSS-1). In order to
monitor stroke course and to estimate the maximal duration
of symptoms within 24 hours, a further examination took
place every 8 hours during the ﬁrst day of hospitalisation
(NIHSS-1a, NIHSS-1b), 24 hours after admission (NIHSS-
2), and ﬁnally at discharge (NIHSS-3). The latter score was
associated with the mRS. These neurological examinations
were all performed by neurologists with NIHSS certiﬁcation.
The NDS was used to assess the variation of the deﬁcit
before admission, to identify the degree of variance in the
course of IS, and to ensure relevance and agreement in
score evolution (NIHSS and NDS). Several NIHSS items
were unknown or insuﬃciently assessed by the GP. This
was most frequent for the following items: dysarthria (21
patients), neglect (11 patients), visual loss (9 patients), and
ataxia (8 patients). For these items, the NIHSS-GP item
was considered to have the same value as the corresponding
NIHSS-1 item if the NDS was stable during the same period.
This score was disregarded if the NDS was unstable during
the same period.
2.3. End Points. The main data concerning the course of
IS are shown in Figure 1. These relate to initial onset of
symptoms (evaluated by NDS), intensity of initial deﬁcit
(evaluated by NIHSS-GP), duration of maximal scores
(“plateau” evaluated by patient’s and/or relatives’ anamnesis
a n dc o n t r o l l e db yt h eN D S ) ,c o u r s eo fd e ﬁ c i t( e v a l u a t e db y
NIHSS and NDS score changes), maximum NIHSS (out of
NIHSS-GP, NIHSS-1, NIHSS-1a, NIHSS-1b, and NIHSS-2)
during the ﬁrst 24 hours (“NIHSS-max”), and maximum
NDS (“NDS-max”). Threshold outcomes were established
based on the symptom duration plateau corresponding to
the average plateau duration estimated by the patient and/or
his/her family once the symptoms had regressed, and by
NIHSS-max for the intensity of signs corresponding to the
average NIHSS-max score in the cohort. A worsening of
neurological deﬁcit was deﬁned as an increase of 4+ points
on the NIHSS and 2+ on the NDS. Conversely, a decrease
of 4+ points on the NIHSS and 2+ points on the NDS
represented a regression. Neurological deﬁcit was considered
stable for variations below 4 and 2 points on the NIHSS and
the NDS respectively.
2.4. Statistical Analysis. Statistical analysis was carried out
using SPSS software, version 13.0 (SPSS Inc. 2005). The Chi-
square test, the Student’s t-test, linear correlation, variance
analysis and ROC curves were used to determine outcome
thresholds. The results were signiﬁcant if P<0.05. Outcome
was considered poor if patients died or were dependent (i.e.,
a score of 4-5 on the mRS) or good if patients were left with
slight or no disability (mRS 0-1).
Thresholds for NIHSS and deﬁcit duration were calcu-
lated using ROC curves. The cut-oﬀs corresponded to the
point of the ROC curve where the tangent to the slope (S)
was equal to S = ((1 − p)/p) · Δ,w h e r ep represents the
prevalence of the group considered as positive according
to the Besanc ¸on Stroke Registry data and Δ represents the
“error overcost” due to false positive (FP) over that due
to false negative (FN), in comparison to real positive (RP)
and real negative (RN) diagnoses. Δ was calculated using
the following formula: Δ = (cost FP-cost RN)/(cost FNcost
RP). Ratio Δ was ﬁxed at 2 in order to increase the positive
predictive value (PPV) (reliability of the prognosis for the
family), and when thrombolysis was considered, the risk of
haemorrhagic transformation when treating by excess, over
the beneﬁt lost when not treating by default. The relative
risks used were the same as those from the meta-analysis of
results obtained by Hacke et al. [12].
PPVandnegativepredictivevalue(NPV)thresholdswere
calculatedusingthefollowingformulae:PPV = p·Se/p·Se +
(1−p)·(1−Sp),andNPV = (1−p)·Sp/(1−p)·Sp+p(1−Se)
where p represents the prevalence of the positive-considered
group in the cohort. Se and Sp represent the sensitivity and
speciﬁcity of the predeﬁned threshold.ISRN Neurology 3
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Figure 1: Analysis of IS course data.
0.7%
12.4%
29.4%
57.5%
74.5%
81.1%
20
40
60
80
100
1236 1 2 1 8 2 4
(hours)
100%
C
u
m
u
l
a
t
i
v
e
f
r
e
q
u
e
n
c
y
(
%
)
Figure 2: Onset to admission delays.
The model was subsequently evaluated on a new and
prospective cohort of 157 patients to validate the sensitivity
and speciﬁcity of the diﬀerent thresholds.
3. Results
3.1. Baseline Characteristics (Table 1). The study population
comprised 154 patients including 88 men and 66 women
(sex ratio 1.33). The mean age was 69.7 years ± 15.6 (22–
96 years). In 36 (23%) patients, the neurological deﬁcit
regressed within 24 hours. In 26 (17%), the clinical presenta-
tion suggested an anterior circulatory system TIA and in the
other 10 (6.5%) a TIA in the posterior circulatory system.
Onset to admission times are outlined in Figure 2. Selected
patients were all admitted within 24 hours of symptom
onset, <3 hours for 45 (29.4%) patients and <6h o u r sf o r8 9
(57.5%).
3.2. Initial Clinical Course. Symptom onset was sudden in
116 (75.3%) patients, progressive in 14 (9.2%), and
unknown in 24 (15.5%). Clinical course during the ﬁrst 24
hours was monophasic in 134 (87%) patients. This repre-
sented a stable initial deﬁcit in 62 (40.2%), a total regression
of symptoms in 36 (23.4%), and a partial regression in 36
(23.4%). In 20 (13%) patients, the initial presentation was
polyphasic, that is, ﬂuctuating in 10 (6.5%) and progressive
in 10 (6.5%).
3.3. Correlation between NDS, NIHSS-1 and NIHSS-GP
Scores (Figure 3). There was a good correlation between the
scores obtained on admission for NDS and NIHSS-1 (r2 =
0.87). This was also the case for NIHSS-GP and NIHSS-1
scores on admission (r2 = 0.79); mean time between the two
physical examinations was 610.7 minutes.
3.4. Inﬂuence of Symptom Duration and Intensity on the
Course of IS and Outcomes (Table 2). Of the 36 TIA patients,
8(22.2%)showedchangesintheirfollow-upimagingstudies
(3 MRI and 5 CT-scan). However, only 12/28 (42.8%)
patients with lesion-free TIA underwent MRI. The severity
of neurological deﬁcit, identiﬁed by NIHSS-max or NDS-
max scores and deﬁcit plateau, was correlated with the type
of ischaemia (lesion-free TIA, TIA with lesion, stroke), but
no signiﬁcant diﬀerences were revealed between lesion-free
TIA and TIA with lesion. In addition, initial deﬁcit severity
and plateau duration were strongly correlated with outcome
after hospitalisation (Table 2).
3.5. Factors Predictive of Outcome. In 150 (97.2%) patients
(χ2 = 44.1; P<0.0001), a regression of the initial neuro-
logical signs within the ﬁrst 24 hours was associated with a
good prognosis (mRS 0-3). However in 92 (59.7%) patients
(χ2 = 49.2; P<0.0001), a stable condition was signiﬁcantly
correlated with a negative prognosis (mRS 4-5 or death).
Nevertheless, there was no signiﬁcant relationship between
the mRS and ﬂuctuating (χ2 = 2.5; P<0.11) or progressive
courses (χ2 = 1.2; P<0.45) within the ﬁrst 24 hours.
3.6. Clinical and Temporal Thresholds Predicting Poor and
Good Outcome (Figure 4). An NIHSS score >22 with a PPV4 ISRN Neurology
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Figure 3: Correlation between NDS and NIHSS-1 (a) and between NIHSS-GP and NIHSS-1 (b).
of 86% and a NPV of 88% (Figure 4(a), left) was predictive
of functional dependence (mRS 4-5) or death. The plateau
duration threshold was 1,230 minutes (PPV = 56% and
NPV = 89%) (Figure 4(a), right). An NIHSS score <5w a s
predictive of good functional outcome with a PPV of 86%
and an NPV of 73% (Figure 4(b), left). The plateau duration
threshold was 135 minutes (PPV = 69% and NPV = 76%)
(Figure 4(b), right).
3.7.ModelEvaluation. Thismodelwasevaluatedandapplied
to a new prospective cohort of 157 patients. Good outcome
prediction (mRS 0-1) showed 91% sensitivity and 88%
speciﬁcity for NIHSS <5 and 100% sensitivity and 51%
speciﬁcity for a plateau duration of <135 min. For NIHSS
>22, the prediction of poor outcome (mRS >3) indicated
95% sensitivity and 85% speciﬁcity, and 67% sensitivity and
100% speciﬁcity for plateau duration >1,230 min.
4. Discussion
Although clinicians managing acute IS beneﬁt from novel
therapeutic approaches and better radiological evaluation,
there is a lack of quantitative clinical criteria to enable IS
to be stratiﬁed according to the vital and functional risks
it generates. This lack of criteria is the result of rigid and
uniform management of IS patients. The highly unpre-
dictable outcome for any given arterial occlusion argues for
a more individualised approach to the dynamic nature of
ischaemia. Speciﬁc clinical criteria and temporal thresholds
are more variable than neuroimaging data, even though
certain models predicting outcome have recently been
reported [13–16]. These models include neuroradiological
variablesandclinicaleventsafteradmission,whichprecludes
theiruseindecision-makingonadmission.Statisticalmodels
that predict functional outcome after stroke using 6 simple
variables may prove useful in epidemiological studies, but
until their impact on patient care and outcome has been
evaluated,theyshouldnotbeappliedtoclinicalmanagement
[17]. A study of the course of IS in the ﬁrst 24 hours and
identiﬁcation of the factors predictive of outcome could
clarify nontreated patients’ evolution using initial clinical
data on admission.
Previous studies have been based on an “a priori” model
in which speciﬁc criteria were used to select patients [12]. In
contrast, the homogeneity and reproducibility of our results
stem from the fact that our study was based on an “a poste-
riori” model involving two consecutive, prospective cohorts
who were all admitted in a routine setting. Covariables that
predict outcome such as age, comorbidity, lesion size, and
penumbra were not included for the statistical power of the
tests andtoensureapracticalapplication ofthe thresholds to
initial clinical management.
Despite the good reproducibility of the NIHSS [18], a
bias may have been introduced by the subjectivity of each
examiner (GPs for NIHSS-GP, neurologist for NIHSS-1).
Moreover, even if some GPs had undergone initial training
in the NIHSS, most of them did not use it regularly. To limit
this bias, we excluded patients when the precise course of
symptoms could not be ascertained (32 patients; 20.8%) or
when GPs could not provide relevant and detailed clinical
data (18 patients; 11.7%). However, data for the NIHSS-
GP items were obtained for all selected patients, except
for disregarded items (dysarthria, neglect, visual loss, and
ataxia). This type of retrospective NIHSS scoring has already
been validated with similar algorithms elsewhere [18, 19]
with excellent reliability (resp. r2 = 0.94, P<0.001 and
86%probabilityofcorrectlyrankingNIHSS).Usingasimilar
methodological algorithm to perform NIHSS-GP, a good
correlation between NIHSS-GP and NIHSS-1 (r2 = 0.79)
was observed even when the two scores were 610 minutes
apart. We feel that reliability is improved by our method inISRN Neurology 5
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Figure 4: ROC curves calculating positive predictive value and negative predictive value. 4(a) For the prediction of a good outcome (mRS
0-1) for predeﬁned clinical (left curve) and temporal (right curve) thresholds. 4(b) For the prediction of a poor outcome (mRS >3) for
predeﬁned clinical (left curve) and temporal (right curve) thresholds.
which unknown NIHSS-GP items were either considered as
equal to the corresponding NIHSS-1 or coded as unknown
and not taken into account. Furthermore, in order to limit
the risk of obtaining incomplete information from the GP,
the patient, or his/her relatives, the history was taken as soon
as possible after admission. We also performed a double
analysis of the NIHSS and NDS scores from the patient’s
perspective. The NDS was used to evaluate the variation
of symptoms before admission. This introduced a further
possible source of bias, particularly due to the lack of
objectivity and precision of the items (side, evaluation of
cognitive disturbance, etc.), but it allowed us to evaluate the
coherence of the temporal course of the initial symptoms
and to ensure relevance and agreement in score evolution.
ThegoodcorrelationsbetweenNIHSS-GPandNIHSS-1and
between NIHSS-1 and NDS (r2 = 0.87) both argue for the
coherence of the diﬀerent results and therefore for a limited
bias.
DeﬁcitdurationinTIAhasalreadybeenwidelydiscussed
in the literature. As far back as 1983, Waxman and Toole
[20] reported on TIA patients with CT scans revealing
cerebral infarction. It was later established that evidence of
recent infarction on cerebral imaging (CT scan or MRI)
was directly correlated with symptom duration [21]. In
1999, two deﬁnitions of TIA were proposed according to
whether symptoms lasted less or more than 1 hour [22].
Since 2004, the duration threshold has been reduced from
24 hours to 60 minutes. In our sample of patients with TIA,
23.4% had an event as deﬁned before 2004, which is higher
than in other comparable studies in the literature. This is
probably due to the way in which medical care is organised
in our hospital’s emergency room [23] and also due to the
low number of exclusions made possible by our ability to
access temporal data with TIA. Among our TIA patients, test
imaging study data were modiﬁed in 22.2% of cases, despite
the low number of MRI studies performed (42.8%). Deﬁcit6 ISRN Neurology
Table 1: Baseline characteristics.
Medical history
Hypertension 55.8%
Cigarette smoking 32.5%
Cardiac dysrhythmia 27.9%
Permanent atrial ﬁbrillation 17.5%
Paroxystic atrial ﬁbrillation 6.7%
Alcohol use 24%
Hyperlipidemia 20.1%
Previous stroke/TIA 15.6%
Arteritis 14.3%
Diabetes mellitus 14.3%
Heart failure 13%
Coronary insuﬃciency 12.2%
Angina pectoris 6.4%
Myocardial infarction 5.8%
Infarct territory
Total MCA infarction 28 (18.5%)
Total superﬁcial MCA infarction 3 (2%)
Partial superﬁcial MCA infarction 30 (19.9%)
Deep MCA infarction 23 (15.2%)
ACA infarction 2 (1.3%)
Anterior circulation TIA 26 (17.3%)
Localised brain stem infarction 11 (7.3%)
Diﬀuse brain stem infarction 2 (1.3%)
Thalamic Infarction 6 (4%)
PCA Infarction 4 (2.6%)
Cerebellar infarction 11 (7.3%)
Posterior circulation TIA 10 (6.6%)
Etiology
Atherothrombotic Stroke
Large artery stenosis >50% 23 (15.3%)
Large artery stenosis <50% 33 (22%)
Microangiopathy 3 (2%)
Cardioembolism 37 (24.7%)
Miscellaneous 4 (2.7%)
Arterial Dissection 1 (0.7%)
Arteritis 1 (0.7%)
Hemopathy/Coagulopathy 3 (2%)
Other 1 (0.7%)
Unknown 48 (31.2%)
Modiﬁed Rankin score at discharge
0-1 73 (47.4%)
2 27 (17.5%)
3 10 (6.5%)
4 15 (9.7%)
5 12 (7.8%)
Death 17 (11%)
severity and duration were on average higher in lesion-free
TIA and lower in IS. Unlike Kimura et al. [22], there was no
signiﬁcant diﬀerence in symptom duration between lesion-
free and nonlesion-free TIA. This is probably due to the
lack of statistical power related to the small number of TIA
patients with lesion. This was true when the mean duration
of symptoms exceeded 7 hours (442 minutes), and the mean
duration of lesion-free TIA deﬁcit (75.2 minutes) was close
t ot h e1h o u rf o u n db yK i m u r ae ta l .[ 22].
The severity of neurological deﬁcit, expressed by the
initial NIHSS, predicted the functional prognosis at the
end of hospitalisation: average initial NIHSS of 5.5 for
nondependent, 17 for dependent, and 24.1 for deceased
patients. Correlations between the severity of initial clinical
presentationandapoorprognosishavebeenreportedinonly
afewstudies[24–28].Inthesestudies,progressivestrokealso
has a poor prognosis, but with a progression time deﬁnition
subject to high variations (from <6 hours to 8 days) [26].
M o r e o v e r ,D e G r a b ae ta l .[ 25] studied the criteria predictive
of negative prognosis and worsening of the initial deﬁcit in
IS. According to these authors, an NIHSS score >7 represents
a negative threshold in terms of worsening and functional
outcome using a qualitative variable.
In our study the duration of neurological deﬁcit was also
a predictive criterion of functional outcome at discharge.
On average, the plateau duration in our sample was >6
hours(399.1minutes)fornondependentpatients,>15hours
(931.5minutes)fordependentpatients,andcloseto24hours
(1,230minutes)forpatientswhodied.Althoughtheseresults
appear evident in clinical practice, there is a dearth of precise
data relating to the duration of the initial neurological deﬁcit
in the literature.
The symptom thresholds that we deﬁned met the
selection requirements of patients for whom a therapeutic
decision was likely to be considered. Here, two opposing
points must be considered. The ﬁrst corresponds to all
patients who are likely to be dependent or dead at discharge;
the prognosis threshold has a therapeutic implication (seri-
ous therapeutic decision) and implications for the family
(negative prognosis announcement, application for nursing
home care). Therefore, a threshold value with a maximum
PPV is required. However, the temporal criteria threshold
obtained was 1,230 minutes, with a PPV of 56% and an NPV
of 89%. This criterion does not appear to accurately predict
poor outcome since it was too long (close to 21 hours),
and it was negative in nearly 50% of cases. Moreover, a
regression of symptoms before this maximum threshold may
also be predictive of an absence of functional dependence or
death (NPV in 89% of cases). In the same way, an initial
NIHSS score >22 was a better predictor of poor prognosis
with a PPV of 86% and an NPV of 88%. This threshold
would seem to more accurately deﬁne those patients who
are more likely to have a poor outcome, even if it fails
in about 10% of cases. Secondly, although recent studies
indicate that patients with mild but disabling symptoms
could be treated with tPA regardless of their baseline NIHSS
score [29, 30], the risk of haemorrhagic transformation
secondary to thrombolysis may be greater than the expected
beneﬁtsforpatientswhosenaturalcourseappearsfavourable
(mRS 0-1). A maximum PPV is therefore required for this
threshold since an aggressive therapy may result. In ourISRN Neurology 7
Table 2: Inﬂuences of symptom duration and intensity on the course of IS.
NDS-0 (IC 95%) NIHSS-GP (IC 95%) Plateau duration (min.) (IC 95%)
Lesion-free TIA (n = 28) 4.31 (3.6–5.1) 2.92 (2.1–3.8) 75.23 (29.6–120.9)
TIA with lesion (n = 8) 8.41 (3.6–13.1) 4.72 (2.2–7.3) 442.53 (25.7–859.3)
Infarction (n = 118) 14.71 (12.6–16.8) 12.12 (10.1–14.1) 727.53 (609.9–845.1)
mRS 0–3 (n = 110) 84 (6.8–9.2) 5.55 (4.3–6.6) 399.16 (296.6–501.6)
mRS 4-5 (n = 27) 19.34 (14.2–24.4) 17.05 (12.8–21.2) 931.56 (684.7–1178.2)
Death (n = 17) 31.54 (28.2–34.8) 24.15 (20.9–27.3) 13206 (1129.8–1510.2)
Table 3: Items assessed in the Neurological Dysfunction Score,
reﬂecting the patient’s and/or his/her family’s evaluation of symp-
toms and their variation prior to assessment on admission.
Motor function
Face Upper limb Lower limb
Unknown
Normal
Could be used
Could not be used
None
Sensitivity
Face Upper limb Lower limb
Unknown
Normal
Slight asymmetry
Clearly reduced
Anaesthesia, no feeling at
all
Cognitive function: speech disturbances, reading writing,
calculating diﬃculties, neglect
Unknown
Normal
Minimal
Diﬃcult to understand
Incomprehensible
Posture and gait
Upright position Gait
Unknown
Normal
Possible alone
Possible with help
Impossible
Limb coordination
Upper limb Lower limb
Unknown
Normal
Slight control
Very little control
No control
study where the initial NIHSS was <5 or when the initial
deﬁcit regressed within the ﬁrst 135 minutes, the expected
beneﬁt of thrombolysis would have been minimal or nil
in 87% and 69% of cases respectively. For initial NIHSS
<5, since the gains and risks of thrombolysis are both low,
it is diﬃcult to diﬀerentiate between the positive eﬀect of
thrombolysisandpatients’naturaloutcome.Inourstudy,for
these two threshold values (initial NIHSS was <5 or initial
deﬁcit regressed within the ﬁrst 135 minutes), the NPV was
acceptable (73% and 76%, respectively). In other words, an
initial NIHSS score >5 represented a good prognosis (mRS
0-1) in only 27% of cases, and a neurological deﬁcit that was
stable for >135 minutes was also a sign of good prognosis in
only 24% of cases.
The NIHSS thresholds as deﬁned in our study are very
similar to those recommended for selecting candidates for
thrombolysis [31]. The duration threshold would not be
applicable though as it is too close to the cut-oﬀ onset-
to-needle time of 180 minutes. Furthermore, if symptoms
start to regress at 135 minutes, thrombolysis may not be
advisable, because in 69% of cases, recovery is likely to
be excellent. This may explain the rationale of Albers et
al. in the STARS study where patients who were admitted
earliest were the last to receive treatment [32]. This raises an
important question over the possible beneﬁts of waiting as
long as possible before commencing thrombolysis in order
to be certain that symptoms are not going to regress, even
if national and international guidelines recommend that it
be administered as early as possible [31, 33]. Conversely,
a less intense set of symptoms lasting for >24 hours does
not seem to have a negative prognosis since this type of
course is frequently encountered in minor infarctions. Thus,
the extent of ischaemic lesions could be approached using a
combinationofclinicalandtemporaldataandtherebydeﬁne
a gradient such as “NIHSS per minute.”
5. Conclusion
In conclusion, predicting natural course and stroke outcome
at the acute phase seems possible. Low (<5) and high (>22)
NIHSS cut-oﬀ points are eﬀective positive predictive values
for good (mRS 0-1) and poor (mRS 4-5 or death) outcomes.
Results are less conclusive for intermediate initial NIHSS or
for thresholds for symptom duration. In order to stratify
decision making, anatomophysiological data resulting from
the use of functional MRI techniques (DWI-PWI) must be
associated with clinicotemporal data in order to establish
precise predictive IS criteria for each individual patient.
Indeed some authors have highlighted a higher probability8 ISRN Neurology
of infarction growth and early neurological deterioration
when a mismatch between clinical data and DWI is observed
[34, 35]. However, it seems that these data alone cannot
identify independent predictors of outcome at 3 months
[36, 37]. In order to stratify decision making, clinical and
temporal variables should be integrated into the equation
alongside neuroimaging data in order to determine natural
outcome, and thus the best course of treatment.
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